834
Participants
Start Date
July 1, 2006
Primary Completion Date
January 1, 2008
Study Completion Date
January 1, 2008
Mometasone furoate/formoterol (MF/F) combination
MF/F 400/10 mcg via a metered dose inhaler (MDI) twice daily for 12 weeks
Mometasone furoate/formoterol (MF/F) combination
MF/F 200/10 mcg via a metered dose inhaler (MDI) twice daily for 12 weeks
Mometasone furoate MDI (MF MDI)
MF 400 mcg via metered dose inhaler twice daily for 12 weeks
Collaborators (1)
Novartis
INDUSTRY
Organon and Co
INDUSTRY